Polymorphisms of haemostasis genes as risk factors for preterm delivery

Thrombosis and Haemostasis

Volumn 94, Issue 1, 2005, Pages 88-92

  Härtel, Christoph ^a   von Otte, Sören ^a   Koch, Julia ^a   Ahrens, Peter ^a   Kattner, Evelyn ^b   Segerer, Hugo ^c   Möller, Jens ^d   Diedrich, Klaus ^a   Göpel, Wolfgang ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Children's Hospital Auf der Bult   (Germany)

^c Klinik St Hedwig   (Germany)

^d Childrens Hospital Saarbrucken   (Germany)

Author keywords

Coagulation system; Factor VII factor XIII; Preterm delivery

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 7; LEUCINE; PROTHROMBIN; VALINE;

ADULT; ARTICLE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEMOSTASIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREMATURE LABOR; PRIORITY JOURNAL; RISK FACTOR; VERY LOW BIRTH WEIGHT;

COHORT STUDIES; FACTOR V; FACTOR VII; FACTOR XIII; FEMALE; GENOTYPE; HEMOSTASIS; HOMOZYGOTE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MALE; MOTHERS; MUTATION; ODDS RATIO; POLYMORPHISM, GENETIC; PREGNANCY; PREMATURE BIRTH; PROTHROMBIN; REGRESSION ANALYSIS; RISK FACTORS; TERM BIRTH;

EID: 22144483101     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-10-0653     Document Type: Article

References (37)

1. Goldenberg R, Rouse D. Medical progress: prevention of premature birth. N Engl J Med 1998; 339: 313-20.
2. Nelson DB, Ness RB, Grisso JA et al. Influence of hemostatic factors on spontaneous abortion. Am J Perinatol 2001; 18: 195-201.
3. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222-31.
4. Rey E, Kahn SR, David M et al. Thrombophilic disorders and foetal loss: a meta-analysis. Lancet 2003; 361: 901-8.
5. Göpel W, Kim D, Gortner L. Prothrombotic mutations as a risk factor for preterm birth. Lancet 1999; 353: 1411-2.
6. Kupferminc MJ, Fait G, Many A et al. Low-molecular-weight heparin for the prevention ob obstretic complications in women with thrombophilias. Hypertens Pregnancy 2001; 20: 35-44.
7. Grandone E, Margaglione M. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications. Thromb Haemost 2004; 2: 1187-8.
8. Brenner B. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications - Yes. J Thromb Haemost 2003; 1: 2070.
9. Gris J-C, Mercier E, Quéré I et al. Low-molecular-weight heparin vesus low-dose aspirin in women with one foctal loss and a constitutional thromboühilic disorder. Blood 2004; 103: 3695-9.
10. Middeldorp S. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications - No. J Thromb Haemost 2003; 1: 2073.
11. Walker MC, Ferguson SE, Allen VM. Heparin for pregnant women with acquired or inherited thrombophilias. Cochrane Database Syst Rev 2003: CD003580.
12. Li D-K, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs durino pregnancy and risk of miscarriage: population based cohort study. Br Med J 2003; 327: 1-5.
13. Nielsen GL, Sørensen HAT, Larsen H et al. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. Br Med J 2001; 322: 266-70.
14. Nielsen GL, Vinther Skriver M, Pedersen L, Sørensen HAT. Danish group reanalyses miscarriage in NSAID user. Br Med J 2004; 328: 109 [Letter].
15. Wells PS, Rodger MA. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications - No. J Thromb Haemost 2004; 2: 1188.
16. Nelson DB, Ness RB, Grisso JA et al. Sex hormones, hemostasis, and early pregnancy loss. Arch Gynecol Obstet 2002; 267: 7-10.
17. Inbal A Muszbek L. Coagulation factor deficiencies and pregnancy loss. Semin Thromb Haemost 2003; 29: 1714.
18. De Maat MPM, Green F, de Knijff P et al. Factor VII polymorphisms in populations with different risks of cardiovascular disease. 1997; 17: 1918-23.
19. Humphries S, Temple A, Lane A et al. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the glutamine 353 variant. Thromb Haemost 1996; 75: 567-72.
20. Kudaravalli R, Tidd T, Pinotti M et al. Polymorphic changes in the 5′flanking region of factor VII have a combined effect on promotor strength. Thromb Haemost 2002; 88: 763-7.
21. Ariens RA, Lai TS, Weisel JW et al. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 2002; 100: 743-54.
22. Kohler HP, Stickland MH, Ossei-Gerning N et al. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8-13.
23. Catto AJ, Kohler HP, Coore J et al. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 1999; 93: 906-8.
24. Elbaz A, Pirier O, Canaple S et al. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 2000; 95: 586-91.
25. Franco RF, Reitsma PH, Lourenco D et al. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis. Thromb Haemost 1999; 81: 676-9.
26. Gopel W, Kattner E, Seidenberg J et al. The effect of the Val34Leu polymorphism in the factor XIII gene in infants with a birth weight below 1500 g. J Pediatr 2002; 140: 688-92.
27. Ridker PM, Hennekens CH, Lindpainter K et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 13: 880-1, 881 ff.
28. Poort SR, Bertina RM, Vos HL. Rapid detection of the prothrombin 20210 A variation by allele specific PCR. Thromb Haemost 1997; 78: 1157-8.
29. Van Hylckama Vlieg A, Komanasin N, Ariens RA et al. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis. Br J Haematol 2002; 119: 169-75.
30. Corral J, Iniesta JA, Gonzalez-Conejero R et al. Polymorphisms of clotting factors modify the risk to primary intracranial hemorrhage. Blood 2001; 97: 2979-82.
31. Walker ID. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications No. Thromb Haemost 2004; 2: 1185.
32. Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Haemost 2003; 29: 125-30.
33. Dizon-Townson DS, Meline L, Nelson LM et al. foetal carriers of the factor-V-Leiden mutation are prone to miscarriae and placental infarction. J Obstet Gynecol 1997; 177: 402-5.
34. Kupferminc MJ, Eldor A. Inherited thrombophilia and gestational vascular complications. Semin Thromb Haemost 2003; 29: 185-94.
35. Mariani G, Herrmann H, Schulman S et al. Thrombosis in inherited factor VII deficiency. Thromb Haemost 2003; 1: 2153-8.
36. Craven CM, Chedwick LR, Ward K. Placental basal plate formation is associated with fibrin deposition in decidual veins at sites of trophoblast cell invasion. Am J Obstet Gynecol 2002; 186: 291-6.
37. Anwar R, Gallivan L, Edmonds SD et al. Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood 1999; 93: 897-905.